Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff8af48e9a475fbd8cd23cbd6f473014 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-72 |
filingDate |
2013-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4416fe7a572062cbe47b302fcec47433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e695601f6e99f12ed3ba66962da7a4e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c7aedc9c1dc63d4fd1469c349627112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f50f1e5e45d6f941e43ed7992af4a3c |
publicationDate |
2014-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
LV-14841-B |
titleOfInvention |
Hybrid and imacrine compounds of quinazolinone and oxadiazole |
abstract |
The present invention relates to the synthesis of novel hybrid molecules cotaining quinazolinone and 1,3,4-oxadiazole moieties which are connected with a linear aliphatic linker. |
priorityDate |
2013-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |